Antibodies

Biochemical Test:SDS-PAGE (purity&gt: 80 %): Western blot with i: anti-M2 autoantibody positive sample: ii: monoclonal anti His-tag antibody.Calculated Isoelectric Point:pH 6.5Coating Concentration:0.4-0.8 µg/ml (depending on the type of ELISA plate

Bebtelovimab (anti-Spike RBD).

Bebtelovimab (anti-Spike RBD).

ApplicationELISA: 1/10000WB: 1/500 - 1/2000FCM: 1/200 - 1/400IHC: 1/200 - 1/1000Protein FunctionPlays a central role in autophagy (By similarity). May play a role in antiviral host defense. Protects against infection by a neurovirulent strain of

ApplicationELISA: 1/10000WB: 1/500 - 1/2000FCM: 1/200 - 1/400IHC: 1/200 - 1/1000Protein FunctionPlays a central role in autophagy (By similarity). May play a role in antiviral host defense. Protects against infection by a neurovirulent strain of

ApplicationELISA: 1/10000WB: 1/500 - 1/2000FCM: 1/200 - 1/400IHC: 1/200 - 1/1000Protein FunctionPlays a central role in autophagy (By similarity). May play a role in antiviral host defense. Protects against infection by a neurovirulent strain of

ApplicationELISA: 1/10000WB: 1/500 - 1/2000FCM: 1/200 - 1/400IHC: 1/200 - 1/1000Protein FunctionPlays a central role in autophagy (By similarity). May play a role in antiviral host defense. Protects against infection by a neurovirulent strain of

Begelomab (anti-DPP4) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab (anti-DPP4) can be used for the research of severe refractory idiopathic inflammatory myopathy.

Begelomab (anti-DPP4) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab (anti-DPP4) can be used for the research of severe refractory idiopathic inflammatory myopathy.

Begelomab (anti-DPP4) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab (anti-DPP4) can be used for the research of severe refractory idiopathic inflammatory myopathy.

Begelomab (anti-DPP4) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab (anti-DPP4) can be used for the research of severe refractory idiopathic inflammatory myopathy.

Belantamab is an anti-TNFRSF17 recombinant monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin.Purity:&gt:95% (SDS-PAGE&amp:SEC)Endotoxin Level:&lt: 1.0EU/mg.